OS benefit for trifluridine/tipiracil in advanced gastric cancer from third-line onward Presented ByProf. Josep Tabernero, Vall d'Hebron Institute of Oncology, Spain TrialTAGS ConferenceASCO GI 2021 12 March, 2021 11:44